A Frailty Scale Predicts Outcomes of Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone on the First Trial

被引：12

作者：

Facon, Thierry ^{[1
]}

Hulin, Cyrille ^{[2
]}

Dimopoulos, Meletios A. ^{[3
]}

Belch, Andrew ^{[4
]}

Meuleman, Nathalie ^{[5
]}

Mohty, Mohamad ^{[6
]}

Chen, Wen-Ming ^{[7
]}

Kim, Kihyun ^{[8
]}

Zamagni, Elena ^{[9
]}

Rodriguez-Otero, Paula ^{[10
]}

Renwick, William ^{[11
]}

Rose, Christian ^{[12
]}

Tempescul, Adrian ^{[13
]}

Palumbo, Antonio ^{[14
]}

Guo, Shien ^{[15
]}

Sturniolo, Michael ^{[16
]}

Ervin-Haynes, Annette ^{[16
]}

Fermand, Jean-Paul ^{[17
]}

机构：

[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[2] CHU BORDEAUX, Bordeaux, France

[3] Univ Athens, Sch Med, Athens 11528, Greece

[4] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[5] Univ Libre Bruxelles, Jules Bordet Insitute, Dept Hematol, Brussels, Belgium

[6] St Antoine Hosp, Dept Haematol, Paris, France

[7] Beijing Chaoyang Hosp, Beijing, Peoples R China

[8] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea

[9] Azienda Osped Univ, Bologna, Italy

[10] Univ Navarra Clin, Pamplona, Spain

[11] Western Hlth, St Albans, Australia

[12] Hop St Vincent, Dept Hematol, Lille, France

[13] CHU Brest, Dept Hematol, F-29285 Brest, France

[14] Univ Turin, Turin, Italy

[15] Evidera, Boston, MA USA

[16] Celgene Corp, Summit, NJ USA

[17] Hop St Louis, AP HP, Serv Immunohematol, Paris, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

10.1182/blood.V126.23.4239.4239

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes
Facon, Thierry
Moreau, Philippe
Weisel, Katja
Goldschmidt, Hartmut
Usmani, Saad Z.
Chari, Ajai
Plesner, Torben
Orlowski, Robert Z.
Bahlis, Nizar
Basu, Supratik
Hulin, Cyrille
Quach, Hang
O'Dwyer, Michael
Perrot, Aurore
Jacquet, Caroline
Venner, Christopher P.
Raje, Noopur
Tiab, Mourad
Macro, Margaret
Frenzel, Laurent
Leleu, Xavier
Cook, Gordon
Wang, George
Pei, Huiling
Krevvata, Maria
Carson, Robin
Borgsten, Fredrik
Kumar, Shaji K.
LEUKEMIA, 2025, : 942 - 950
[42] Impact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results
Dimopoulos, Meletios A.
Cheung, Matthew C.
Roussel, Murielle
Liu, Ting
Gamberi, Barbara
Kolb, Brigitte
Derigs, H. Guenter
Eom, Hyeon Seok
Belhadj, Karim
Lenain, Pascal
van der Jagt, Richard H.
Rigaudeau, Sophie
Dib, Mamoun
Hall, Rachel
Jaccard, Arnaud
Tosikyan, Axel
Karlin, Lionel
Bensinger, William
Schots, Rik
Chen, Guang
Marek, Jennifer
Ervin-Haynes, Annette
Facon, Thierry
BLOOD, 2014, 124 (21)
[43] Isatuximab Plus Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus Vrd in Chinese Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant: IMROZ Subgroup Analysis
An, Gang
Liu, Zhuogang
Jin, Jie
Cai, Zhen
Li, Wei
Xia, Zhongjun
Cen, Xinan
Hu, Yu
Mi, Jian-Qing
Jing, Hongmei
Zhan, Rong
Qu, Xiaoyan
Du, Xin
Gao, Dan
Zhao, Liang
Qiu, Lugui
BLOOD, 2024, 144 : 7055 - 7056
[44] Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma
Wang, Yan
Liu, Yuan-Fang
Jin, Shi-Wei
Tao, Yi
Zhang, Wei-Ping
Chen, Jian-Lin
Jiang, Song-Fu
Mi, Jian-Qing
SCIENTIFIC REPORTS, 2025, 15 (01):
[45] Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone: Results of the phase III E4A03 trial for newly diagnosed patients
Muneer, Sabeeha
Cunningham, Sonia
CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (01): : 17 - 18
[46] Ocular adverse events in transplant ineligible patients with newly diagnosed multiple myeloma treated with belantamab mafodotin plus lenalidomide/dexamethasone from the phase 1/2 BelaRd study
Terpos, Evangelos
Ntanasis-Stathopoulos, Ioannis
Gavriatopoulou, Maria
Malandrakis, Panagiotis
Fotiou, Despina
Migkou, Magdalini
Theodorakakou, Foteini
Spiliopoulou, Vasiliki
Syrigou, Rodanthi
Papaiakovou, Evangelos Eleutherakis
Gkolfinopoulos, Stavros
Manousou, Kyriaki
Kastritis, Efstathios
Dimopoulos, Meletios A.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[47] Bortezomib, Lenalidomide and Low-Dose Dexamethasone (VRD) Versus Lenalidomide and Low-Dose Dexamethasone (Ld) for Newly-Diagnosed Multiple Myeloma- a Randomized Phase III Study
Mookerjee, Anjali
Gupta, Ritu
Jasrotia, Shivali
Sahoo, Ranjit
Kumar, Rakesh
Thulkar, Sanjay
Sharma, Om Dutt
Kumar, Lalit
BLOOD, 2017, 130
[48] Daratumumab plus Lenalidomide/ dexamethasone in transplant-neligible patients with newly diagnosed multiple myeloma: MAIA update
Basu, Supratik
Kumar, Shaji K.
Moreau, Philippe
Bahlis, Nizar
Facon, Thierry
Plesner, Torben
Orlowski, Robert Z.
Nahi, Hareth
Hulin, Cyrille
Quach, Hang
Goldschmidt, Hartmut
O'Dwyer, Michael
Perrot, Aurore
Venner, Christopher P.
Weisel, Katja
Raje, Noopur
Tiab, Mourad
Macro, Margaret
Frenzel, Laurent
Leleu, Xavier
Pei, Huiling
Krevvata, Maria
Borgsten, Fredrik
Usmani, Saad Z.
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 17 - 18
[49] Minimal Residual Disease Status Predicts Progression-Free Survival in Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated with Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (KRd)
Jasielec, Jagoda
Dytfeld, Dominik
Griffith, Kent A.
McDonnell, Kathryn
Lebovic, Daniel
Kandarpa, Malathi
Anderson, Tara
Mietzel, Melissa
Faham, Malek
Lee, Liana
Levy, Joan
Alonge, Mattina
Rosebeck, Shaun
Kaminski, Mark
Jakubowiak, Andrzej
BLOOD, 2014, 124 (21)
[50] Cost-effectiveness of lenalidomide plus dexamethasone vs bortezomib plus melphalan and prednisone in transplant-ineligible US patients with newly-diagnosed multiple myeloma
Usmani, S. Z.
Cavenagh, J. D.
Belch, A. R.
Hulin, C.
Basu, S.
White, D.
Nooka, A.
Ervin-Haynes, A.
Yiu, W.
Nagarwala, Y.
Berger, A.
Pelligra, C. G.
Guo, S.
Binder, G.
Gibson, C. J.
Facon, T.
JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) : 243 - 258

← 1 2 3 4 5 →